1. Potent and direct antioxidant activity2. Improves HDL function (enhances RCT) rather than merely increasing HDL-C quantity3. Leads to regression of xanthomas in patients with FH4. Possesses an LDL-receptor-independent mechanism for lipid lowering. The gene discussed is LDLR; the disease is xanthoma.